Clinical Trial

SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers

Study acronym: SDMPOSSIBLE
Recruiting
View on ClinicalTrials.gov →
Summary
Investigators aim to conduct a type 1 hybrid effectiveness-implementation surgeon-level cluster randomized clinical trial (RCT) of a multi-level intervention, a shared decision making training for surgeons plus patient decision aid vs. usual care (UC), at 7 large health systems across the U.S. to learn the intervention's effectiveness. Decision aids will be mailed and sent via patient portal and/or via email (when portal/email addresses are available) to patients before their first surgical encounter. The central hypothesis is that the novel intervention will be a key resource to support shared decision making leading to higher quality treatment decisions and as result improved care and outcomes.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-03-24; most recent amendment 2026-04-06.
Status change: Not Yet Recruiting → Recruiting 2026-02-12
Trial Details
NCT Number NCT06896474
Lead Sponsor Beth Israel Deaconess Medical Center
Conditions Breast Cancer
Enrollment 402 participants
Start Date 2026-02-04
Primary Completion 2032-10-01 (estimated)
Study Completion 2033-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-07